Evidence map›Paper›PMID 40898330›Full record

ReviewSubstance abuse treatment, prevention, and policy2025

Tobacco and asthma: presenting the world health organization (WHO) tobacco knowledge summary.

Wenying Lu, Sarah Rylance, Kerstin Schotte, Rebekka Aarsand, Elizaveta Lebedeva, Werner Bill, Jing Han, David Cl Lam, Joan B Soriano, Arzu Yorgancioglu and 1 more

Abstract readReview
In one paragraph

Review in Substance abuse treatment, prevention, and policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wenying LuRespiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, The Shed Building, 80 Cimitiere Street, Launceston, TAS, 7250, Australia.
Sarah RylanceDepartment of Noncommunicable Diseases, Rehabilitation and Disability, World Health Organization, Geneva, Switzerland.
Kerstin SchotteDepartment of Health Promotion, World Health Organization, Geneva, Switzerland.
Rebekka AarsandDepartment of Digital Health and Innovation, World Health Organization, Geneva, Switzerland.
Elizaveta LebedevaTobacco Control Unit, Special Initiative on NCDs and Innovation, World Health Organization, Regional Office for Europe, Copenhagen, Denmark.
Werner BillEuropean Respiratory Society (ERS), Lausanne, Switzerland.
Jing HanDepartment of Noncommunicable Diseases, Rehabilitation and Disability, World Health Organization, Geneva, Switzerland.
David Cl LamDepartment of Medicine, School of Clinical Medicine, University of Hong Kong, Hong Kong SAR, China.
Joan B SorianoServicio de Neumología, Hospital Universitario de la Princesa; Facultad de Medicina, Universidad Autónoma de Madrid; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, all in Madrid, Madrid, Spain.
Arzu YorganciogluDepartment of Pulmonology, Medical Faculty, Celal Bayar University, Global Initiative for Asthma (GINA), Manisa, Turkey.
Sukhwinder Singh SohalRespiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, The Shed Building, 80 Cimitiere Street, Launceston, TAS, 7250, Australia. sukhwinder.sohal@utas.edu.au.

Funding

Clifford Craig Foundation Launceston General Hospital P202World Health Organization 001
6 · The paper itself

Abstract

The WHO recently published a Tobacco Knowledge Summary (TKS) which is prepared with the objective to summarize the current evidence on the association between tobacco use and asthma. This is also intended as an advocacy tool to widely include health care professionals in the fight for tobacco control and prevention of tobacco related adverse health effects. This article expands on the evidence outlined in the TKS, providing a more comprehensive and clinically focused analysis, aimed at lung-specialist audience. It emphasizes six key messages aimed at guiding healthcare providers and governments in advocating for the health of people living with asthma and the broader population: (1) Babies born to mothers who smoke have smaller lungs and an increased risk of developing asthma during childhood. Pregnant women should receive targeted support to quit tobacco use. (2) Children exposed to second-hand tobacco smoke have an increased risk of developing asthma. (3) Smoking during adolescence and adulthood increases the risk of developing asthma and exacerbates the condition, as well as causing other lung diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer. (4) For people living with asthma, smoking worsens symptoms and can make treatment with medications less effective. All smokers with asthma should be supported to quit smoking. (5) E-cigarettes, heated tobacco products and other nicotine-delivery devices likely also carry risks. Governments should implement effective tobacco control measures to protect all individuals, including those who are vulnerable. (6) The tobacco and nicotine industries' aggressive tactics in the marketing of their products specifically target children, adolescents and young adults. Protecting youth from these harmful tactics is a top priority.

Indexed as

AsthmaHealth Knowledge, Attitudes, PracticeChildFemaleHumansPregnancySmoking CessationTobacco Smoke PollutionWorld Health OrganizationTobacco Smoke PollutionAsthmaSmoking and vapingSmoking cessationTobacco control

Identifiers

PMID40898330
PMCPMC12406344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.